Salud Bienestar

Forest Labs says Icahn may have won one board seat



    (Reuters) - Drugmaker Forest Laboratories Inc said on Wednesday it believes that billionaire investor Carl Icahn secured one out of four board seats he was targeting in a proxy battle.

    The company said Icahn nominee Pierre Legault would likely replace current director Dan Goldwasser, who serves as chairman of the compensation committee.

    (Reporting by Soyoung Kim; Editing by Gerald E. McCormick)